ZA944140B - Imidazole lipoxygenase inhibitors - Google Patents

Imidazole lipoxygenase inhibitors

Info

Publication number
ZA944140B
ZA944140B ZA944140A ZA944140A ZA944140B ZA 944140 B ZA944140 B ZA 944140B ZA 944140 A ZA944140 A ZA 944140A ZA 944140 A ZA944140 A ZA 944140A ZA 944140 B ZA944140 B ZA 944140B
Authority
ZA
South Africa
Prior art keywords
alkyl
substituted
independently
alkoxy
halo
Prior art date
Application number
ZA944140A
Other languages
English (en)
Inventor
Rodney W Stevens
Takashi Mano
Kazuo Ando
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA944140B publication Critical patent/ZA944140B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA944140A 1993-06-14 1994-06-13 Imidazole lipoxygenase inhibitors ZA944140B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14220693 1993-06-14

Publications (1)

Publication Number Publication Date
ZA944140B true ZA944140B (en) 1995-12-13

Family

ID=15309865

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944140A ZA944140B (en) 1993-06-14 1994-06-13 Imidazole lipoxygenase inhibitors

Country Status (23)

Country Link
US (1) US5753682A (zh)
EP (1) EP0703913B1 (zh)
KR (1) KR100190728B1 (zh)
CN (2) CN1050840C (zh)
AT (1) ATE154353T1 (zh)
AU (1) AU685122B2 (zh)
BR (1) BR9406822A (zh)
CA (1) CA2163667C (zh)
CZ (1) CZ282969B6 (zh)
DE (1) DE69403795T2 (zh)
DK (1) DK0703913T3 (zh)
ES (1) ES2103130T3 (zh)
FI (1) FI942792A (zh)
GR (1) GR3024568T3 (zh)
HU (1) HUT70767A (zh)
IL (1) IL109903A (zh)
NO (1) NO955046L (zh)
NZ (1) NZ266541A (zh)
PL (2) PL176522B1 (zh)
RU (1) RU2126004C1 (zh)
TW (1) TW374088B (zh)
WO (1) WO1994029299A1 (zh)
ZA (1) ZA944140B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063928A (en) * 1994-10-18 2000-05-16 Pfizer Inc 5-lipoxygenase inhibitors
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
CA2232267C (en) * 1995-09-18 2002-06-11 Pfizer Inc. Novel imidazole lipoxygenase inhibitors
US6194585B1 (en) * 1998-12-22 2001-02-27 Pfizer Inc. Process for preparing 5-lipoxygenase inhibitors
US6344563B1 (en) * 1999-08-31 2002-02-05 Timothy Norris Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems
MX2009005526A (es) 2006-11-27 2009-06-05 Pfizer Prod Inc Analogos de pirazol.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
EP0106440B1 (en) * 1982-08-12 1987-11-25 Smith and Nephew Associated Companies p.l.c. Wound dressing and its manufacture
JPS60142966A (ja) * 1983-09-05 1985-07-29 Yoshitomi Pharmaceut Ind Ltd イミダゾ−ル誘導体
US4851526A (en) * 1987-09-04 1989-07-25 Schering A.G. 1-(4-Substituted phenyl)-1H-imidazoles compounds
US5234950A (en) * 1988-12-23 1993-08-10 Imperial Chemical Industries Plc Tetrahydrofuran derivatives
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
US5223525A (en) * 1989-05-05 1993-06-29 Rhone-Poulenc Ag Company Pesticidal 1-arylimidazoles
IE64358B1 (en) * 1989-07-18 1995-07-26 Ici Plc Diaryl ether heterocycles
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
GB9101375D0 (en) * 1991-01-22 1991-03-06 Erba Carlo Spa N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
GB9108811D0 (en) * 1991-04-24 1991-06-12 Erba Carlo Spa N-imidazolyl derivatives of substituted indole

Also Published As

Publication number Publication date
US5753682A (en) 1998-05-19
RU2126004C1 (ru) 1999-02-10
NO955046D0 (no) 1995-12-13
PL176522B1 (pl) 1999-06-30
HUT70767A (en) 1995-10-30
NZ266541A (en) 1997-11-24
IL109903A (en) 1998-10-30
IL109903A0 (en) 1994-10-07
EP0703913A1 (en) 1996-04-03
CZ282969B6 (cs) 1997-11-12
DE69403795D1 (de) 1997-07-17
EP0703913B1 (en) 1997-06-11
NO955046L (no) 1996-02-13
FI942792A0 (fi) 1994-06-13
CN1247191A (zh) 2000-03-15
PL175987B1 (pl) 1999-03-31
WO1994029299A1 (en) 1994-12-22
CN1125442A (zh) 1996-06-26
PL312006A1 (en) 1996-04-01
GR3024568T3 (en) 1997-12-31
HU9401762D0 (en) 1994-09-28
AU6807794A (en) 1995-01-03
DE69403795T2 (de) 1997-09-18
KR100190728B1 (ko) 1999-06-01
CA2163667C (en) 1998-12-15
ATE154353T1 (de) 1997-06-15
DK0703913T3 (da) 1997-10-20
CZ327695A3 (en) 1996-05-15
BR9406822A (pt) 1996-03-26
FI942792A (fi) 1994-12-15
TW374088B (en) 1999-11-11
CA2163667A1 (en) 1994-12-22
CN1050840C (zh) 2000-03-29
AU685122B2 (en) 1998-01-15
ES2103130T3 (es) 1997-08-16
KR960703121A (ko) 1996-06-19

Similar Documents

Publication Publication Date Title
HU9600278D0 (en) Remedy for nervous diseases
BR0308146A (pt) Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
DE69431974D1 (de) Benzamid-Derivate und ihre Verwendung als Vasopressin-Antagonisten
DK0874812T3 (da) Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf
FR2705343B1 (fr) Dérivés de beta,beta-diméthyl-4-pipéridineéthanamine, leur procédé de préparation et leur utilisation en thérapeutique.
GR3024568T3 (en) Imidazole lipoxygenase inhibitors
GB9727521D0 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
DK0748314T3 (da) Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
KR960706476A (ko) 인터류킨-1 활성 억제제로서의 신규한 벤젠설포닐아민 유도체(Novel benzen-esulfonylimine derivatives as inhibitors of lL-1 action)
ATE159255T1 (de) Chinuclidine derivate als squalen synthase inhibitoren
DE59604901D1 (de) Carbamoylcarbonsäureamide
CA2253795A1 (en) Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
BR0014759A (pt) Inibidores de metaloprotease beta dissubstituìdos
AU4486796A (en) Imidazole derivatives, their preparation and their use as sadenosylmethionine decarboxylase (=samdc) inhibitors
WO2002026708A1 (fr) Composes conenant de l'azote et inhibiteurs de ccr3 contenant ces composes en tant que principe actif
DK0710233T3 (da) Heteroarylcycloalkenylhydroxyurinstoffer
BR0116240A (pt) Mistura fungicida, método para controlar fungos nocivos, e, usos dos compostos de amida e dos derivados de imidazol
ES2187775T3 (es) Imidazopiridinas.
NO992870D0 (no) Difenylalkyl-tetrahydropyridiner, fremgangsmÕter for deres fremstilling og farmas°ytiske blandinger inneholdende dem
BR9907301A (pt) Composto, processo para preparar um composto, composição farmacêutica, e, processo para tratar uma condição de doença